Discounted Cash Flow Rating

Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Sell

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Allarity Therapeutics, Inc. Common Stock (ALLR)

Pharmaceutical Preparations

https://www.allarity.com

Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improve clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.

24 SCHOOL ST., 2ND FLOOR
BOSTON, MA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

12/21/2021

Market Cap

6,912,098

Shares Outstanding

5,890,000

Weighted SO

5,886,934

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

IMMX --.--%

CNSP --.--%

EFTR --.--%

NAVB --.--%

SONN --.--%

VIRI --.--%

ZURA --.--%

ZVSA --.--%

QNRX --.--%

Beta

0.2790

Last Div

0.0000

Range

0.138-38.2

Chg

0.0006

Avg Vol

6079806

Mkt Cap

6912098

Exch

NASDAQ

Country

US

Phone

401 426 4664

DCF Diff

1.1426

DCF

-0.5696

Div Yield

0.0000

P/S

61.7152

EV Multiple

0.6505

P/FV

0.1232

Div Yield %

0.0000

P/E

-0.1917

PEG

0.0025

Payout

-0.0179

Current Ratio

2.0073

Quick Ratio

2.0073

Cash Ratio

1.8117

DSO

5145.8482

DIO

0.0000

Op Cycle

5145.8482

DPO

94328.1667

CCC

-89182.3185

Gross Margin

0.7321

Op Margin

-151.0357

Pretax Margin

-113.0982

Net Margin

-113.8036

Eff Tax Rate

-0.0055

ROA

-0.4127

ROE

-7.0478

ROCE

-0.8347

NI/EBT

1.0062

EBT/EBIT

0.7488

EBIT/Rev

-151.0357

Debt Ratio

0.0429

D/E

0.0668

LT Debt/Cap

0.0000

Total Debt/Cap

0.0626

Int Coverage

132.1563

CF/Debt

-11.8875

Equity Multi

1.5570

Rec Turnover

0.0709

Pay Turnover

0.0039

Inv Turnover

0.0000

FA Turnover

6.5882

Asset Turnover

0.0036

OCF/Share

-1.0515

FCF/Share

-1.0515

Cash/Share

1.2840

OCF/Sales

-140.6339

FCF/OCF

1.0000

CF Coverage

-11.8875

ST Coverage

-11.8875

CapEx Coverage

0.0000

Div&CapEx Cov

-69.0833

P/BV

0.1232

P/B

0.1232

P/S

61.7152

P/E

-0.1917

P/FCF

-0.4388

P/OCF

-0.1551

P/CF

-0.1551

PEG

0.0025

P/S

61.7152

EV Multiple

0.6505

P/FV

0.1232

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Dec 06, 22:38 Allarity Therapeutics, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. November 12, 2024 Deadline to file Lead Plaintiff Motion GlobeNewswire Inc. Nov 08, 00:20 ALLR FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Allarity Therapeutics, Inc. Investors to Secure Counsel Before Important November 12 Deadline in Securities Class Action – ALLR GlobeNewswire Inc. Nov 06, 03:16 ???? ????? ?????? ??? ALLER: ????, ???? ???????? ?????? ?????, ????? ?? ?????? Allarity Therapeutics, Inc ?????? ????? ???? ????? ??? ???? ?? 12 ??????? ?????? ??????? ??????? ??? – ALLR GlobeNewswire Inc. Nov 02, 18:01 ALLR ????????????????? ROSEN ?? Allarity Therapeutics, Inc. ????????????????? 11 ? 12 ? ?????? - ALLR GlobeNewswire Inc. Oct 30, 01:00 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against GitLab, Allarity, ZoomInfo, and Agenus and Encourages Investors to Contact the Firm GlobeNewswire Inc. Oct 29, 03:29 Allarity Therapeutics, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. November 12, 2024 Deadline to file Lead Plaintiff Motion. GlobeNewswire Inc. Oct 26, 23:23 ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Allarity Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ALLR GlobeNewswire Inc. Oct 23, 23:47 ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Allarity Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ALLR GlobeNewswire Inc. Sep 30, 22:34 ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Allarity Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ALLR GlobeNewswire Inc. Sep 16, 23:04 Investor Notice: Robbins LLP Informs Stockholders of the Class Action Lawsuit Filed Against Allarity Therapeutics, Inc. GlobeNewswire Inc. Aug 03, 21:23 ALLARITY THERAPEUTICS, INC. ANNOUNCEMENT: If You Have Suffered Losses in Allarity Therapeutics, Inc. (NASDAQ: ALLR), You Are to Contact The Rosen Law Firm About Your Rights GlobeNewswire Inc. Dec 12, 06:00 Allarity Therapeutics Announces Thomas Jensen as Interim CEO and Appointment of Jeremy R. Graff, PhD as Key Executive Advisor Benzinga Dec 06, 14:43 Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session GlobeNewswire Inc. Dec 05, 07:30 Allarity’s Early Phase 2 Stenoparib Data Indicates Clinical Benefit in Women with Advanced Ovarian Cancer Selected with DRP® Companion Diagnostic

Revenue Product Segmentation